Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Aquestive Therapeutics Inc (NQ: AQST)
7.130   +0.510 (+7.70%)
Official Closing Price  /  Updated: 4:53 PM EDT, Aug 14, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,405,471
Open 6.670
Bid (Size) 7.150 (1)
Ask (Size) 7.250 (5)
Prev. Close 6.620
Today's Range 6.670 - 7.340
52wk Range 1.410 - 10.00
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
+18.24%
+18.24%
1 Month
+72.64%
+72.64%
3 Month
+31.55%
+31.55%
6 Month
+62.79%
+62.79%
1 Year
+101.98%
+101.98%
Top News
More News
Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Treatment of Allergic Reactions Including Anaphylaxis
from GlobeNewswire News Releases
Aquestive Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update: AQST-108 Progress Remains On Track; Libervant PDUFA Goal Date Approaches
from GlobeNewswire News Releases
More News
Read More
Aquestive Therapeutics to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
from GlobeNewswire News Releases
Aquestive Therapeutics to Announce Second Quarter Financial Results and Recent Business Highlights on Aug 4 and Host Conference Call on Aug 5 at 8:00 a.m. ET
from GlobeNewswire News Releases
Aquestive Therapeutics Files IND for Pharmacokinetic Clinical Trials of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment
from GlobeNewswire News Releases
Aquestive Therapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
from GlobeNewswire News Releases
Aquestive Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders
from GlobeNewswire News Releases
Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval
from GlobeNewswire News Releases
How The Parts Add Up: IWO Targets $249
category ETFs
from ETF Channel
Aquestive Therapeutics, Inc. (AQST) Q2 2020 Earnings Call Transcript
category Market News , AQST
from Motley Fool
Thinking about buying stock in Xeris Pharmaceuticals, Aquestive Therapeutics, Navidea Biopharmaceuticals, Sundial Growers, or Hexo Corp?
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.